Table 3. Biochemical and biopsy outcome for localised prostate cancer treated with HIFU.

Follow-up (months)	3	6	9	12	18	24
N	155	120	103	83	63	23
Biochemical parameters
PSA (ng ml−1)
<0.05
n	64	43	36	29	26	10
%	41.2	35.8	35.0	35.0	41.3	43.5
⩽0.2
n	108	78	60	48	36	14
%	69.7	65.0	58.3	57.8	57.1	60.9
⩽0.5
n	129	94	83	65	47	19
%	83.2	78.3	80.6	78.3	74.6	82.6